| Ticker Details |
|
Monte Rosa Therapeutics, Inc.
|
| IPO Date: |
June 24, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.22B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.44 | 4.24%
|
| Avg Daily Range (30 D): |
$0.90 | 4.44%
|
| Avg Daily Range (90 D): |
$0.69 | 3.46%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
1.15M |
| Avg Daily Volume (90 D): |
.96M |
| Trade Size |
| Avg Trade Size (Sh.): |
84 |
| Avg Trade Size (Sh.) (30 D): |
71 |
| Avg Trade Size (Sh.) (90 D): |
66 |
| Institutional Trades |
| Total Institutional Trades: |
661 |
| Avg Institutional Trade: |
$2.52M |
| Avg Institutional Trade (30 D): |
$2.16M |
| Avg Institutional Trade (90 D): |
$2.67M |
| Avg Institutional Trade Volume: |
.19M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.12M |
| Avg Closing Trade (30 D): |
$3.19M |
| Avg Closing Trade (90 D): |
$3.95M |
| Avg Closing Volume: |
194.3K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
|
|
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
|
$8.97M
|
$4.21M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-161.09M
|
$-43.4M
|
$-44.5M
|
|
Operating Income / Loss
|
|
$-49.13M
|
$-50.03M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
|
$-69.76M
|
$29.97M
|
|
PE Ratio
|
|
|
|
|
|
|